Bio-Techne (TECH) Q4 2024 Earnings
TECH·Reported February 5, 2025·Before market open·FQ2 FY2025
Bio-Techne reported Q4 2024 revenue of $297.0M, missed analyst consensus of $317.5M by $20.5M. Diluted EPS came in at $0.42, beat the $0.39 consensus by $0.03.
Revenue
$297.0Mmissed by $20.5M
Consensus: $317.5MDiluted EPS
$0.42beat by $0.03
Consensus: $0.39
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Bio-Techne's Q4 2024 earnings report.
Bio-Techne (TECH) reported Q4 2024 earnings on February 5, 2025 before market open.
Bio-Techne reported revenue of $297.0M and diluted EPS of $0.42 for Q4 2024.
Revenue missed the consensus estimate of $317.5M by $20.5M. EPS beat the consensus estimate of $0.39 by $0.03.
You can read the 10-Q periodic report (0001558370-25-000689) directly on SEC EDGAR. The filing index links above go to sec.gov.